Skip to main content
. 2021 Nov 27;18:239. doi: 10.1186/s12978-021-01287-5

Table 6.

Sociodemographic characteristics of hormonal contraceptive and IUD users by follow-up status

Variables Followed-up sample Lost-to-follow-up sample
N = 560 N = 233
% 95% CI % 95% CI
LL UL LL UL
Age
 15–24 27.0 22.3 32.4 41.6 33.1 50.7
 25–34 43.7 38.8 48.7 39.5 30.7 49.1
 35+ 29.3 25.1 33.9 18.8 13.3 25.9
Mean (in years) 30.3 29.5 31.2 27.2 26.1 28.3
Married or in-union 86.8 82.1 90.4 73.2 62.9 81.4
Urban 16.7 10.1 26.2 27.3 17.1 40.7
Parity
 0–1 13.9 10.1 18.0 32.0 23.1 42.4
 2–3 33.4 27.8 39.4 33.6 25.8 42.3
 4+ 52.7 45.6 59.8 34.4 25.8 44.2
Education
 None 7.2 4.6 11.0 8.5 4.6 15.2
 Primary 57.2 50.5 63.5 56.8 46.2 66.8
 Secondary+ 35.7 29.1 42.8 34.7 24.7 46.3
Wealth
 Lowest 40% 34.7 28.2 41.8 32.1 23.8 41.6
 Highest 60% 65.3 58.3 71.7 67.9 58.4 76.2
Fertility desires
Want in 1–2 years 12.2 9.1 16.2 17.3 12.1 24.1
 Want in 2+ years 42.6 36.8 48.6 50.7 42.8 58.5
 Do not want anymore 45.2 39.5 51.1 32.0 24.8 40.2
Using < 12 months 51.4 45.8 56.9 63.2 55.2 70.6
Method
 Implant 31.9 26.8 37.4 35.3 26.8 44.7
 IUD 4.6 2.7 7.6 2.5 1.1 5.6
 Injectable 56.8 50.6 62.8 53.2 44.7 61.6
 Pill 6.8 4.6 9.8 9.0 4.5 17.5
Number of side effects
 None 77.2 72.1 81.7 73.5 65.1 80.6
 1 4.8 3.0 7.5 5.3 2.5 10.8
 2 or more 18.0 13.8 23.0 21.2 14.2 30.4
Specific side effect
 Less bleeding 9.3 6.2 13.6 10.8 5.7 19.4
 More bleeding 5.6 3.5 9.0 5.0 2.5 9.7
 Irregular bleeding 7.3 4.4 11.9 6.8 3.5 12.9
 Changes to sexual experience 5.4 3.1 9.2 6.6 3.0 13.8
 Physical discomfort 13.1 9.2 18.4 15.4 10.5 22.0